ARDS
Aridis Pharmaceuticals Inc. Common Stock
ARDS
ARDS
Delisted
ARDS was delisted on the 18th of July, 2023.
4 hedge funds and large institutions have $161K invested in Aridis Pharmaceuticals Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$22K |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
2
Millennium Management
New York
|
$134K |
| 3 |
SPIA
3
Steward Partners Investment Advisory
New York
|
$0 |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| $134K | 12,112 | -11,473 | -49% |
|
|
2
UBS Group
Zurich,
Switzerland
| $22K | 2,026 | +217 | +12% |
|
3
Wells Fargo
San Francisco,
California
| $3K | 300 | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $2K | 158 | -467 | -75% |
|
|
5
Goldman Sachs
New York
| – | – | -28,348 | Closed |
|
|
SPIA
6
Steward Partners Investment Advisory
New York
| – | – | -1,000 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|